The Media Perspective
Whether we like it or not, we need to face the fact that there is a new scenario in drug safety and risk communication, and that new players are appearing on the health care scene. Among these new players are the media in their role as communicators to and on behalf of the public. Although the media have embraced the role of watchdog for health matters, the quality of information provided by the media is, at present, rather poor. The reason for this is twofold: pharmaceutical companies are not trained in communicating with journalists and journalists lack basic knowledge of biostatics and pharmacoepidemiology. Both of these gaps must be filled if we are to see an improvement in drug safety information.
KeywordsPharmaceutical Company Risk Communication Health Matter Pharmacoepidemiological Study Defensive Medicine
Unable to display preview. Download preview PDF.